Document is current
Any future updates will be listed below
-
Authors
Popova, Katerina https://orcid.org/0009-0003-0701-9644
Benedum, Johannes https://orcid.org/0000-0003-4475-7577
Engl, Magdalena https://orcid.org/0000-0001-6455-895X
Lütgendorf-Caucig, Carola https://orcid.org/0000-0002-9860-5141
Fossati, Piero
Widder, Joachim https://orcid.org/0000-0002-9972-6690
Podar, Klaus
Slade, Dea https://orcid.org/0000-0002-0052-5910
-
Funding
Funding for this research was provided by:
Technopol (K3-F-730/003-2020)
- License Information
-
More Information
Article History
Received: 25 November 2024
Revised: 25 February 2025
Accepted: 3 March 2025
First Online: 24 March 2025
Disclosure and competing interests statement
: KlP has received speaker’s honoraria from Celgene, Amgen Inc., and Janssen Pharmaceuticals, consultancy fees from Celgene, Takeda, and Janssen Pharmaceuticals, and research support from Roche Pharmaceuticals. The authors declare no competing interests.
